ProShare Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Sell |
|
|||||
|
2025
Q1 | $355K | Sell |
|
|||||
|
2024
Q4 | $361K | Buy |
|
|||||
|
2024
Q3 | $302K | Buy |
|
|||||
|
2024
Q2 | $227K | Sell |
|
|||||
|
2024
Q1 | $307K | Buy |
|
|||||
|
2023
Q4 | $223K | Buy |
|
|||||
|
2023
Q3 | $207K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $253K | Sell |
|
|||||
|
2019
Q3 | $331K | Sell |
|
|||||
|
2019
Q2 | $378K | Sell |
|
|||||
|
2019
Q1 | $362K | Buy |
|
|||||
|
2018
Q4 | $229K | Sell |
|
|||||
|
2018
Q3 | $340K | Sell |
|
|||||
|
2018
Q2 | $421K | Sell |
|
|||||
|
2018
Q1 | $389K | Sell |
|
|||||
|
2017
Q4 | $498K | Buy |
|
|||||
|
2017
Q3 | $382K | Buy |
|
|||||
|
2017
Q2 | $318K | Sell |
|
|||||
|
2017
Q1 | $360K | Sell |
|
|||||
|
2016
Q4 | $552K | Buy |
|
|||||
|
2016
Q3 | $544K | Sell |
|
|||||
|
2016
Q2 | $541K | Buy |
|
|||||
|
2016
Q1 | $324K | Sell |
|
|||||
|
2015
Q4 | $477K | Buy |
|
|||||
|
2015
Q3 | $380K | Sell |
|
|||||
|
2015
Q2 | $637K | Sell |
|
|||||
|
2015
Q1 | $671K | Buy |
|
|||||
|
2014
Q4 | $506K | Buy |
|